NEWS TIPS & FEATURES

Many Early Onset Colon Cancers are Caused by Genetic Mutations Passed Through Families

One in every six colorectal cancer patients (16 percent) diagnosed under age 50 has at least one inherited genetic mutation that increases his or her [...]


Gradalis Announces a Novel Combination Study of Vigil® EATC in Women with Advanced Ovarian Cancer

Gradalis, Inc. a clinical stage cellular immunotherapy company, developing Vigil® Engineered Autologous Tumor Cell (EATC) therapy, announced that it has entered into a collaboration agreement [...]


Do Social Connections Lower Death Rates from Breast Cancer?

Women diagnosed with breast cancer have greater rates of survival and lower rates of disease recurrences if they have more social ties, compared to women [...]


Keytruda®/Halaven® Combo May Be Effective in Advanced Triple-Negative Breast Cancer

The investigative treatment combination including Keytruda® (pembrolizumab) plus Halaven® (eribulin) could provide a potential therapeutic option for patients with advanced triple-negative breast cancer (TNBC) whose [...]


CTI BioPharma Announces Removal Of Full Clinical Hold On Pacritinib

CTI BioPharma Corp. announced that the full clinical hold (February 2016) implemented by the U.S. Food and Drug Administration (FDA) on all clinical trials conducted [...]


Gazyva® Delays Cancer Progression as Initial Therapy in Advanced Follicular Lymphoma

Among patients with advanced follicular lymphoma who have not received prior therapy, treatment with Gazyva® (obinutuzumab) plus chemotherapy delays cancer progression compared to the standard [...]


Aimed Alliance Releases Poll Showing Americans Want Health Insurers To Stop Interfering with Their Treatment

The Alliance for the Adoption of Innovations in Medicine (Aimed Alliance) released the results of a poll showing that Americans value innovative treatments, are willing [...]


Keytruda® Data Demonstrating Activity in Mesothelioma Presented at 17th World Conference on Lung Cancer

Recently updated findings from the phase 1b KEYNOTE-028 study investigating the use of Keytruda® (pembrolizumab) were featured in an oral presentation at the 17th World Conference [...]


ASTRO Expands Guidelines for Treatment of Breast Cancer with Accelerated Partial Breast Irradiation

According to the American Society for Radiation Oncology (ASTRO) younger patients with early stage breast cancer and individuals with low-risk ductal carcinoma in situ (DCIS) [...]


10 Ways to Reduce Your Cancer Risk

There is no magic pill for preventing cancer, but if you want to reduce your risk of developing the disease, there is something you can [...]


« More News Tips & Features